Search Results - Cheikh Ndour
- Showing 1 - 5 results of 5
-
1
-
2
Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans by Wivine Burny, Arnaud Marchant, Caroline Hervé, Andrea Callegaro, Magalie Caubet, Laurence Fissette, Lien Gheyle, Catherine Legrand, Cheikh Ndour, Fernanda Tavares Da Silva, Robbert van der Most, Fabienne Willems, Arnaud M. Didierlaurent, Juan Pablo Yarzábal
Published 2019Artigo -
3
Safety of Seasonal Malaria Chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine when Delivered to Children under 10 Years of Age by District Health Services in Sen... by Jean Louis Ndiaye, B. Cissé, El Hadj Bâ, Jules F. Gomis, Cheikh Ndour, Jean-François Molez, F. Fall, Cheikh Sokhna, Babacar Faye, E. Kouevijdin, F. K. Niane, Matt Cairns, J F Trape, C. Rogier, Oumar Gaye, Brian Greenwood, Paul Milligan
Published 2016Artigo -
4
Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial by Milagritos D. Tapia, Samba O. Sow, Khardiata Diallo Mbaye, Aliou Thiongane, B Ndiaye, Cheikh Ndour, Souleymane Mboup, Babajide Keshinro, Thompson Kinge, Guy Vernet, Jean Joël Bigna, Stephen Oguche, Kwadwo A. Koram, Kwaku Poku Asante, Patrice Gobert, Wayne Hogrefe, Iris De Ryck, Muriel Debois, Patricia Bourguignon, Erik Jongert, W R Ballou, Marguerite Koutsoukos, François Roman, Senate Amusu, Leo Ayuk, Catherine Bilong, Owusu Boahen, Makhtar Camara, Fadima Cheick Haidara, D Coly, Siry Dièye, David Dosoo, Melanie Ekedi, Irma Eneida Almeida Dos Santos, Seyram Kaali, Afoke Kokogho, Myron M. Levine, Nick Opoku, Seth Owusu‐Agyei, Simon Pitmang, Fatima Sall, Moussa Seydi, Marcelo B. Sztein, Mathurin Cyrille Tejiokem, Awa Traoré, Guy Vernet, Abena Kunadu Yawson
Published 2020Artigo -
5
Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial by Milagritos D. Tapia, Samba O. Sow, B Ndiaye, Khardiata Diallo Mbaye, Aliou Thiongane, Cheikh Ndour, Souleymane Mboup, Julie A. Ake, Babajide Keshinro, Akindiran Akintunde, Thompson Kinge, Guy Vernet, Jean Joël Bigna, Stephen Oguche, Kwadwo A. Koram, Kwaku Poku Asante, Wayne Hogrefe, Stephan Günther, Abdi Naficy, Iris De Ryck, Muriel Debois, Patricia Bourguignon, Erik Jongert, W R Ballou, Marguerite Koutsoukos, François Roman, Senate Amusu, Leo Ayuk, Catherine Bilong, Owusu Boahen, Makhtar Camara, Fadima Cheick Haidara, D Coly, Siry Dièye, David Dosoo, Melanie Ekedi, Irma Eneida Almeida Dos Santos, Seyram Kaali, Afoke Kokogho, Myron M. Levine, Nick Opoku, Seth Owusu‐Agyei, Simon Pitmang, Fatima Sall, Moussa Seydi, Marcelo B. Sztein, Mathurin Cyrille Tejiokem, Awa Traoré, Guy Vernet, Abena Kunadu Yawson
Published 2020Artigo
Search Tools:
Related Subjects
Medicine
Immunology
Internal medicine
Ebola virus
Immunogenicity
Reactogenicity
Alternative medicine
Antibody
Computer science
Disease
Pathology
Placebo
Vaccination
Virology
Virus
Adverse effect
Alum
Amodiaquine
Chloroquine
Clinical trial
Cluster (spacecraft)
Cohort
Data mining
Ebola vaccine
Environmental health
Ethnology
HBsAg
Hepatitis B
Hepatitis B vaccine
Hepatitis B virus